Protein 1 | Protein 2 | Combine Score |
---|---|---|
ELN | FBLN5 | 0.99 |
ELN | LOX | 0.99 |
FBLN5 | LOXL1 | 0.983 |
MFAP2 | ELN | 0.974 |
ELN | LOXL1 | 0.973 |
FBLN5 | LOX | 0.969 |
LOXL2 | ELN | 0.966 |
MFAP2 | FBLN5 | 0.96 |
BMP1 | LOX | 0.959 |
ELN | LOXL3 | 0.958 |
MFAP2 | LOXL1 | 0.956 |
ELN | LOXL4 | 0.956 |
LOXL2 | BMP1 | 0.953 |
BMP1 | LOXL3 | 0.953 |
BMP1 | LOXL1 | 0.95 |
MFAP5 | ELN | 0.948 |
MFAP2 | LOX | 0.948 |
LOX | PCOLCE | 0.941 |
LOXL1 | PCOLCE | 0.939 |
LOXL2 | LOXL1 | 0.936 |
MFAP5 | FBLN5 | 0.935 |
BMP1 | LOXL4 | 0.934 |
LOXL1 | LOX | 0.934 |
MFAP5 | LOX | 0.933 |
LOXL2 | LOX | 0.933 |
LOXL1 | LOXL4 | 0.928 |
FBLN5 | LOXL4 | 0.927 |
LOXL2 | FBLN5 | 0.927 |
LOXL2 | PCOLCE | 0.926 |
LOXL3 | LOXL1 | 0.925 |
FBLN5 | LOXL3 | 0.925 |
LOXL4 | TLL1 | 0.925 |
LOXL2 | TLL1 | 0.922 |
MFAP2 | MFAP5 | 0.922 |
LOX | TLL1 | 0.921 |
MFAP5 | LOXL1 | 0.92 |
LOXL2 | MFAP2 | 0.92 |
LOXL4 | LOX | 0.92 |
LOXL1 | TLL1 | 0.919 |
LOXL3 | LOX | 0.917 |
TLL2 | PCOLCE | 0.913 |
TLL2 | LOXL4 | 0.909 |
LOXL2 | MFAP5 | 0.907 |
LOXL2 | LOXL3 | 0.907 |
LOXL3 | PCOLCE | 0.907 |
LOXL2 | LOXL4 | 0.907 |
LOXL2 | TLL2 | 0.906 |
LOXL3 | LOXL4 | 0.906 |
TLL2 | LOX | 0.905 |
LOXL4 | PCOLCE | 0.905 |
TLL2 | LOXL1 | 0.903 |
MFAP2 | LOXL4 | 0.902 |
MFAP2 | LOXL3 | 0.902 |
LOXL3 | TLL1 | 0.902 |
MFAP5 | LOXL4 | 0.902 |
MFAP5 | LOXL3 | 0.902 |
TLL2 | LOXL3 | 0.901 |
# | 2006 (ELN) | 10516 (FBLN5) | 4237 (MFAP2) | 4017 (LOXL2) | 649 (BMP1) | 8076 (MFAP5) | 4015 (LOX) | 4016 (LOXL1) | 84695 (LOXL3) | 84171 (LOXL4) | 7093 (TLL2) | 5118 (PCOLCE) | 7092 (TLL1) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2006 (ELN) | 1.00 | 0.83 | 1.00 | 0.47 | 0.43 | 1.00 | 0.52 | 0.16 | 0.53 | 0.52 | 0.12 | 0.73 | 0.12 |
10516 (FBLN5) | 0.83 | 1.00 | 0.71 | 0.53 | 0.52 | 0.71 | 0.61 | 0.16 | 0.60 | 0.61 | 0.12 | 0.66 | 0.10 |
4237 (MFAP2) | 1.00 | 0.71 | 1.00 | 0.34 | 0.26 | 1.00 | 0.26 | 0.16 | 0.26 | 0.26 | 0.12 | 1.00 | 0.13 |
4017 (LOXL2) | 0.47 | 0.53 | 0.34 | 1.00 | 0.45 | 0.34 | 0.69 | 1.00 | 0.83 | 0.69 | 0.16 | 0.47 | 0.12 |
649 (BMP1) | 0.43 | 0.52 | 0.26 | 0.45 | 1.00 | 0.26 | 0.49 | 0.28 | 0.50 | 0.49 | 1.00 | 0.44 | 0.70 |
8076 (MFAP5) | 1.00 | 0.71 | 1.00 | 0.34 | 0.26 | 1.00 | 0.26 | 0.16 | 0.26 | 0.26 | 0.12 | 1.00 | 0.13 |
4015 (LOX) | 0.52 | 0.61 | 0.26 | 0.69 | 0.49 | 0.26 | 1.00 | 1.00 | 0.86 | 1.00 | 0.16 | 0.50 | 0.15 |
4016 (LOXL1) | 0.16 | 0.16 | 0.16 | 1.00 | 0.28 | 0.16 | 1.00 | 1.00 | 1.00 | 1.00 | 0.16 | 0.16 | 0.16 |
84695 (LOXL3) | 0.53 | 0.60 | 0.26 | 0.83 | 0.50 | 0.26 | 0.86 | 1.00 | 1.00 | 0.86 | 0.16 | 0.52 | 0.13 |
84171 (LOXL4) | 0.52 | 0.61 | 0.26 | 0.69 | 0.49 | 0.26 | 1.00 | 1.00 | 0.86 | 1.00 | 0.16 | 0.50 | 0.15 |
7093 (TLL2) | 0.12 | 0.12 | 0.12 | 0.16 | 1.00 | 0.12 | 0.16 | 0.16 | 0.16 | 0.16 | 1.00 | 0.12 | 1.00 |
5118 (PCOLCE) | 0.73 | 0.66 | 1.00 | 0.47 | 0.44 | 1.00 | 0.50 | 0.16 | 0.52 | 0.50 | 0.12 | 1.00 | 0.10 |
7092 (TLL1) | 0.12 | 0.10 | 0.13 | 0.12 | 0.70 | 0.13 | 0.15 | 0.16 | 0.13 | 0.15 | 1.00 | 0.10 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LOX | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 31.2 | RT-qPCR | Western US | C57BL/6 mice | –3.9 | 7600m mice(8% oxygen with Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
LOX | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 3.9 | RT-qPCR | Western US | C57BL/6 mice | –3.9 | 7600m mice(8% oxygen with no Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT018405 | hsa-miR-335-5p | Homo sapiens | LOX | 4015 | Homo sapiens | Microarray | Functional MTI (Weak) | 18185580 |
MIRT437550 | hsa-miR-29a-3p | Homo sapiens | LOX | 4015 | Homo sapiens | Luciferase reporter assay | Functional MTI | 22745231 |
MIRT437556 | hsa-miR-29b-3p | Homo sapiens | LOX | 4015 | Homo sapiens | qRT-PCR | Functional MTI (Weak) | 25744716 |
MIRT437556 | hsa-miR-29b-3p | Homo sapiens | LOX | 4015 | Homo sapiens | Luciferase reporter assay//qRT-PCR | Functional MTI | 23354167 |
MIRT437556 | hsa-miR-29b-3p | Homo sapiens | LOX | 4015 | Homo sapiens | Luciferase reporter assay | Functional MTI | 22745231 |
MIRT437571 | hsa-miR-767-5p | Homo sapiens | LOX | 4015 | Homo sapiens | Luciferase reporter assay | Functional MTI | 22745231 |
MIRT437561 | hsa-miR-29c-3p | Homo sapiens | LOX | 4015 | Homo sapiens | Luciferase reporter assay | Functional MTI | 22745231 |
MIRT438051 | hsa-miR-200b-3p | Homo sapiens | LOX | 4015 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 23975428 |
MIRT442618 | hsa-miR-4743-3p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT442622 | hsa-miR-142-3p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT442626 | hsa-miR-548e-5p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT442624 | hsa-miR-3120-5p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT442623 | hsa-miR-6830-3p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT442620 | hsa-miR-511-5p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT442619 | hsa-miR-3591-5p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT442621 | hsa-miR-6888-3p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT442625 | hsa-miR-4280 | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 22100165 |
MIRT731147 | hsa-miR-30a-5p | Homo sapiens | LOX | 4015 | Homo sapiens | Western blot//Luciferase reporter assay//Immunohistochemistry | Functional MTI | 25488748 |
MIRT761778 | hsa-miR-1271-5p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 27292025 |
MIRT763003 | hsa-miR-182-5p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 27292025 |
MIRT769463 | hsa-miR-4470 | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 27292025 |
MIRT769935 | hsa-miR-4517 | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 27292025 |
MIRT774726 | hsa-miR-5583-3p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 27292025 |
MIRT782596 | hsa-miR-889-3p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 27292025 |
MIRT782998 | hsa-miR-9-5p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 27292025 |
MIRT783005 | hsa-miR-96-5p | Homo sapiens | LOX | 4015 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 27292025 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
4015 | GO:0048545 | response to steroid hormone | GOTERM_BP_DIRECT |
4015 | GO:0004720 | non-membrane spanning protein tyrosine kinase activity | GOTERM_MF_DIRECT |
4015 | GO:0005507 | copper ion binding | GOTERM_MF_DIRECT |
4015 | GO:0005581 | collagen trimer | GOTERM_CC_DIRECT |
4015 | GO:0006464 | cellular protein modification process | GOTERM_BP_DIRECT |
4015 | GO:0005615 | extracellular space | GOTERM_CC_DIRECT |
4015 | GO:0005576 | extracellular region | GOTERM_CC_DIRECT |
4015 | GO:0030199 | collagen fibril organization | GOTERM_BP_DIRECT |
4015 | GO:0035904 | aorta development | GOTERM_BP_DIRECT |
4015 | GO:0016641 | oxidoreductase activity | GOTERM_MF_DIRECT |
4015 | GO:0007507 | heart development | GOTERM_BP_DIRECT |
4015 | GO:0030198 | extracellular matrix organization | GOTERM_BP_DIRECT |
4015 | GO:0042493 | response to drug | GOTERM_BP_DIRECT |
4015 | GO:0030324 | lung development | GOTERM_BP_DIRECT |
4015 | GO:0042060 | wound healing | GOTERM_BP_DIRECT |
4015 | GO:0005578 | proteinaceous extracellular matrix | GOTERM_CC_DIRECT |
4015 | GO:0048251 | elastic fiber assembly | GOTERM_BP_DIRECT |
4015 | GO:0055114 | oxidation-reduction process | GOTERM_BP_DIRECT |
4015 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
4015 | GO:0005634 | nucleus | GOTERM_CC_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
LOX | 4015 | Marfan Syndrome | C0024796 | Disease or Syndrome | 0.31 | 0.488 | 0.793 | disease |
LOX | 4015 | Hepatitis B | C0019163 | Disease or Syndrome | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Liver Cirrhosis | C0023890 | Disease or Syndrome | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Oral Submucous Fibrosis | C0029172 | Disease or Syndrome | 0.32 | 0.488 | 0.793 | disease |
LOX | 4015 | Aortic Valve Insufficiency | C0003504 | Disease or Syndrome | 0.4 | 0.488 | 0.793 | disease |
LOX | 4015 | Primary biliary cirrhosis | C0008312 | Disease or Syndrome | 0.31 | 0.488 | 0.793 | disease |
LOX | 4015 | Biliary cirrhosis | C0023892 | Disease or Syndrome | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Biliary Cirrhosis, Secondary | C0238065 | Disease or Syndrome | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Fibrosis, Liver | C0239946 | Disease or Syndrome | 0.31 | 0.488 | 0.793 | disease |
LOX | 4015 | Liver Cirrhosis, Experimental | C0023893 | Experimental Model of Disease | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Prenatal Injuries | C0086468 | Injury or Poisoning | 0.3 | 0.488 | 0.793 | group |
LOX | 4015 | Pulmonary Hypertension | C0020542 | Pathologic Function | 0.3 | 0.488 | 0.793 | phenotype |
LOX | 4015 | Hepatitis C | C0019196 | Disease or Syndrome | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Hepatic Form of Wilson Disease | C1527352 | Disease or Syndrome | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Osteosarcoma | C0029463 | Neoplastic Process | 0.33 | 0.488 | 0.793 | disease |
LOX | 4015 | Hepatolenticular Degeneration | C0019202 | Disease or Syndrome | 0.32 | 0.488 | 0.793 | disease |
LOX | 4015 | AORTIC ANEURYSM, FAMILIAL THORACIC 10 | C4284414 | Disease or Syndrome | 0.6 | 0.488 | 0.793 | disease |
LOX | 4015 | Ehlers-Danlos Syndrome | C0013720 | Disease or Syndrome | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Congenital aneurysm of ascending aorta | C0345050 | Congenital Abnormality | 0.3 | 0.488 | 0.793 | disease |
LOX | 4015 | Aortic Aneurysm, Thoracic | C0162872 | Disease or Syndrome | 0.32 | 0.488 | 0.793 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|